🇨🇦 Blood component B in Canada

Blood component B (Blood component B) regulatory status in Canada.

Marketing authorisation

Blood component B in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Blood component B approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Blood component B in Canada?

Università degli Studi di Ferrara is the originator. The local marketing authorisation holder may differ — check the official source linked above.